In today’s era of exponential data growth, real-world data (RWD) is abundant, but its value hinges on our ability to interpret it with speed, scale, and precision. That’s where artificial intelligence (AI) comes into play. At TriNetX, we’re seeing firsthand how the...
As I sat down with Dr. Monique Adams of Sanofi for our most recent episode of The Future Prescription: Inside the Trends vodcast, I was reminded just how critical it is to move conversations about representativeness in clinical trials from aspiration to action....
Download the Infographic The Most Cited. The Most Trusted. TriNetX Real-World Data Leading the Way. TriNetX is the most cited EHR dataset in peer-reviewed publications. Cited more often, by more researchers, than our top competitors Outpacing the field by a wide...
In my role at TriNetX, I have the privilege of engaging with leaders across the clinical research landscape who are challenging the status quo and pushing us toward a more inclusive, tech-enabled, and patient-first future. One of the most rewarding conversations I’ve...
As clinical trials evolve, one thing is certain: representativeness is no longer a nice-to-have; it’s a non-negotiable. The data are clear. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, 84% reported ramping up efforts to improve...
Reflecting on the discussions from this year’s International Society for Pharmacoepidemiology (ISPE) Annual Meeting and looking ahead to the future of the field, I’m struck by the steady but significant evolution pharmacoepidemiology is undergoing driven in large part...
